By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

New Haven Pharmaceuticals 

P.O. Box 586

Guilford  Connecticut  06437  U.S.A.
Phone: 770-329-0074 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
New Haven Pharmaceuticals Presents Survey Results That Showed High Risk Cardiovascular Patients Believed That There Are Generally Greater Benefits Associated With Prescription Versus OTC Medications 3/8/2016 6:17:16 AM
New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA Is Well Tolerated And Delivers Sustained 24-Hour Antiplatelet Control 3/1/2016 1:14:05 PM
New Haven Pharmaceuticals Announces Availability of DURLAZA, First And Only Once-Daily 24-Hour Aspirin 1/8/2016 6:55:02 AM
New Haven Pharmaceuticals President Named 2015 Entrepreneur Of The Year By Connecticut United For Research Excellence (CURE) 12/16/2015 9:39:28 AM
New Haven Pharmaceuticals: Study Shows DURLAZA (aspirin) Extended-Release Capsules Delivers Sustained Antiplatelet Effects For Full 24 Hours 11/10/2015 9:49:53 AM
New Haven Pharmaceuticals To Share DURLAZA (aspirin) Extended-Release Capsules Study Data At American Heart Association Scientific Sessions Fall Event 11/2/2015 10:19:41 AM
New Haven Pharmaceuticals Receives FDA Approval For DURLAZA (Aspirin) Extended Release Capsules For Secondary Prevention Of Stroke And Acute Cardiac Events 9/8/2015 9:32:41 AM
New Haven Pharmaceuticals Expands Management Team With Two Senior-Level Appointments 10/8/2014 10:43:29 AM
New Haven Pharmaceuticals Appoints Larry Dillaha, M.D. As Executive Vice President Operations 4/2/2014 6:36:01 AM
Connecticut Innovations Makes Follow-On Investment In New Haven Pharmaceuticals 1/30/2014 9:18:55 AM
12
//-->